Press Releases
Newsletters
AGT Newsletter Volume 11
Newsletter Vol. 11 HIV Program Update Enrolled First Cohort Since our last Newsletter, AGT has enrolled its first cohort of six participants in its Phase 1 study of AGT103-T against HIV. Updates on the RePAIR Cl...
AGT Newsletter Volume 10
VOLUME 10 September 2020 Newsletter We’ve achieved a number of significant milestones this quarter, including the Food and Drug Administration (FDA) clearance to begin Phase 1 of our HIV cure program. The excit...
AGT Newsletter Volume 9
VOLUME 9 May 2020 Newsletter FDA Progress The Path to the Clinic For the HIV Cure This month, AGT saw tremendous progress with the FDA. FDA time and attention to our project has seemed to increase while agency...
Happy New Year! AGT Newsletter – 2020 Edition
A STELLAR 2019 Has Positioned AGT For A SPECTACULAR 2020. I wanted to take a moment to sum up a great year of progress and success at AGT and to talk about potential milestones and significant inflection points ...
Latest Videos
Published Articles
Latest From The Blog
Join Our Newsletter
Subscribe to our newsletter to keep up to date with all the latest news about AGT!
Latest AGT Tweets
An indomitable will from two different #RareDisease moms saves lives. Watch how Amber was able to find a diagnosis for her son and today push for a #SLC6A1 cure, while Brittany raised $2 million to save the lives of #SMARD patients https://t.co/VG0GvtUNsz
@SLC6A1_Mom @smashSMARD
#NEWS: American Gene Technologies Appoints Dr. Robert R. Redfield as Special Advisor to the CEO https://t.co/vIZ0zpF86b
#HIVnews #HIV #biotech #healthcare
If you care about the history and future of HIV, you are going to want to listen to and share this interview with Dr. Tony Fauci and Jeff Galvin. #HIV #hivcure #hope https://t.co/Tw3TmTDagD
